Elizabeth Arden–The beauty products maker reported a loss of $1.04 per share, wider than the 34 cent loss predicted by analysts, with revenue also well below forecasts. The drop was due in part to a steeper than expected sales drop for celebrity fragrances, particularly those from Taylor Swift and Justin Bieber.
Dick's Sporting Goods–The sporting goods retailer reported quarterly profit of 67 cents per share, excluding certain items, beating estimates by two cents. Sales continue to drop in the golf and hunting categories, but the rest of Dick's sales categories saw a 7.8 percent comparable sales increase over a year earlier.
Urban Outfitters—The retailer matched estimates by reporting second quarter profit of 49 cents per share. Revenue was above forecasts, but expenses were higher and comparable store sales at Urban Outfitters fell 10 percent. The company, however, did see same-store sales increases at its Free People and Anthropologie units.
Aeropostale–Aeropostale has rehired former chief executive officer Julian Geiger, replacing Thomas Johnson. The teen apparel retailerhas posted losses for six consecutive quarters.
Sprint–The wireless giant has unveiled new mobile pricing plans that offer 20 gigabytes of shared data for up to 10 lines, as well as unlimited talk and texting for $100 month.
Rackspace–The stock will be on watch today as activist investor Blue Harbour Group builds a 6.4 percent stake in the provider of cloud computing services. Rackspace had said in May that it was exploring strategic options.
Bank of America–BofA executive Thomas Montag will become the bank's only chief operating officer, according to Bloomberg, with co-COO Dave Darnell taking on new duties as vice chairman and continuing to oversee global wealth and investment management.
BHP Billiton–BHP plans to spin off $16 billion in assets to shareholders in the form of a new company, although the mining company disappointed some investors by not also announcing a stock buyback.
AstraZeneca–The drug maker has been cleared by the U.S. government in a case involving the drug trial used to win approval for its Brilinta heart treatment. The government had been questioning the way the trial was conducted, but the company said the probe has been closed and no further action is planned.
Skilled Healthcare Group–The company is combining with privately held Genesis Healthcare in an all-stock transaction. The combination of the long-term care facility operators will use the Genesis Healthcare name.
Eli Lilly –Lilly has won tentative FDA approval for the diabetes treatment Basaglar. However, the approval is subject to a stay of up to 30 months because of patent litigation being brought by France's Sanofi.
Nokia–The stock was downgraded to "underweight" from "neutral" at JPMorgan Chase.
—By CNBC's Peter Schacknow
Questions? Comments? Email us at firstname.lastname@example.org